UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Explore the different types of credit card rewards available. Knowing your options can help you maximize your financial benefits.
15,296 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Three stocks mispriced right could offer substantial upside for patient investors. This article breaks down why these...
Carvana, known for online used-car sales, is making a curious bet on Stellantis. This article explains the rationale,...
Geopolitical tensions can rattle markets in the short term, but history favors patient investors. This guide explains...
Chip Wilson, founder of Lululemon, remains a disruptive voice as he pushes for board changes while the company prepar...
Switzerland tightens regulation and traders seek safer, cost-effective access to the forex market. This report highli...
Deeptune raises $43 million in a Series A led by Andreessen Horowitz to build immersive training gyms for AI agents. ...
Geopolitics and energy markets collide as Iran-related headlines drive price moves. Investors are reassessing risk, h...
History says you'll regret not buying Amazon stock if you wait for perfect timing. This guide breaks down the lessons...
Tech weakness pressured theStreet today, dragging the broader market even as select companies posted government contr...
Chewy just popped. stock momentum followed a better-than-expected 2026 outlook, even as Q4 growth stayed modest. This...